Related Experiment Videos
Use of oxycodone in pain management
Mohammad Moradi1, Sara Esmaeili1, Saeed Shoar1
1Development Association of Clinical Studies (DACS), Tehran University of Medical Sciences (TUMS), Tehran, Iran ; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Anesthesiology and Pain Medicine
|June 7, 2014
Summary
Extended-release oxycodone effectively manages moderate-to-severe chronic pain, including osteoarthritis pain. This formulation demonstrates long-term safety and efficacy, improving patient quality of life with a similar adverse event profile to other opioids.
Area of Science:
- Pharmacology
- Pain Management
- Drug Development
Background:
- Oxycodone is a widely used analgesic for moderate-to-severe acute and chronic pain.
- It is effective for various pain types, including cancer-related pain and neuropathic pain.
- Patient quality of life is improved with oxycodone treatment.
Purpose of the Study:
- To review the efficacy and safety of extended-release oxycodone.
- To discuss its role in managing diverse pain conditions.
- To highlight advancements in pain management through novel drug formulations.
Main Methods:
- Review of existing literature on oxycodone formulations.
- Analysis of clinical data regarding extended-release oxycodone efficacy.
- Assessment of safety profiles and adverse events associated with oxycodone use.
Main Results:
- Extended-release oxycodone (developed in 2011) offers sustained analgesia for chronic pain.
- Significant improvement in osteoarthritis pain was observed with the extended-release formulation.
- Adverse event profiles were comparable to other opioid analgesics.
Conclusions:
- Extended-release oxycodone is a safe and effective option for long-term management of moderate-to-severe chronic pain.
- The development of extended-release formulations enhances therapeutic outcomes in pain management.
- Oxycodone continues to be a vital tool in improving patient quality of life across various pain conditions.